Thus, we investigated Stathmin 1 expression in PB CD34+ cells from healthy donors and patients with PV, ET and PMF and we also stratified the MPN patients according to the presence, or not, of JAK2V617F and CALR mutations. This evidence concerns the gene CALR and myeloproliferative disorder.